Dr. Jefferson Mark Prichard, MD

Dr. Prichard practices at Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health.

Dr. Prichard's NPI, 1609899400, was assigned on July 25, 2006. Dr. Prichard graduated from Medical College of Georgia School of Medicine in 2000. Dr. Prichard holds Virginia license 0101232678.

Dr. Prichard's primary practice is Sentara RMH Medical Center, at 2010 Health Campus Drive, Harrisonburg, VA 22801 in Harrisonburg City. The practice phone is (540) 689-1000.

Dr. Prichard's primary practice is Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health. Dr. Prichard is also affiliated with University Medical Center. The medical group on file is Sentara RMH Medical Group. Dmand AI also links Dr. Prichard to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prichard practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Prichard's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Prichard is licensed in Virginia.

CMS data shows 2,882 Medicare services from Dr. Prichard across 11 procedure codes in 2024, for 584 Medicare patients. Medicare paid $159,779 for them.

CMS counts 584 Medicare patients who saw Dr. Prichard in 2024. The largest group is 75 to 84, with 259 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prichard's median patient age at 72, with 50% women.

In 2024, Dr. Prichard wrote 2,967 Medicare Part D claims for 352 patients. 72% of them were for generic drugs. CMS names the drug for 2,481 of them, across 68 drugs with 11 or more claims each, at $9,510,816 in total drug cost. In 2023, CMS named 1,961 claims across 54 drugs.

Dr. Prichard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Prichard, published from 2011 to 2013. The most frequent topics are Transplantation, Autologous. Dr. Prichard's most frequent co-authors are Christopher Robert Flowers, MD, Amelia A. Langston, MD and Sagar Lonial, MD.

Dmand AI links Dr. Prichard to 5 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Rectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 6 general payments to Dr. Prichard from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $183.

Dr. Prichard graduated from Medical College of Georgia School of Medicine in 2000.